The Triglyceride-Glucose (TyG) index is a marker used to assess insulin resistance which is associated with the occurrence of gestational diabetes. The aim of this study is to determine the benefit of the TyG within the diagnosis of insulin resistance in pregnant women in an orally induced hyperglycaemia test. This study was conducted at the Department of Biochemistry, at Aristide le Dantec University Hospital in collaboration with the department of gynaecology. Women with fasting blood glucose < 0.92 g/L at 12 weeks of age benefited from the OGTT 75 test following the WHO protocol. The TyG index was calculated using the formula: Ln [fasting triglyceridemia (mg/dL) × fasting blood glucose (mg/dL)]/2. Data were analysed using SPSS v.26 and a p< value of 0.05 was considered statistically significant. A total of 102 patients were included in the study with a mean age of 29± to 5.9 years. The OGTT 75 test was positive in 24 women (23.5%) with a predominance in the third trimester (19.4%). TyG values were significantly higher in women with gestational diabetes (8.76, ±0.5vs8.2±, 0.5; p<0.0001), in contrast to the HOMA index (6.43, ±16.8, ±1.15±, 0.9; p=0.138). The AUC of the ROC curve for the TyG-H0, TyG-H1 and TyG-H2 indices were 0.808 (95% CI)=0.70-0.92), 0.808 (95% CI)=0.698-0.918), 0.818 (95% CI)=0.70-0.93, respectively. For the HOMA-IR index, the AUC was 0.799 (95% CI = 0.69-0.91). The cut-off value for the TyG-H1 index was 9.5 with a sensitivity and specificity of 79.2% and 71.8%, respectively. The TyG index is a better way to assess the level of insulin resistance in pregnant women than using the HOMA index, especially after the first hour of a glucose load of 75g.
Published in | Advances in Biochemistry (Volume 12, Issue 3) |
DOI | 10.11648/j.ab.20241203.11 |
Page(s) | 92-98 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
TyG Index, HOMA-IR, Insulin Resistance, OGTT 75g, Gestational Diabetes
Characteristics | Number | Percentage | |
---|---|---|---|
Age (years) | < 30 | 51 | 50 |
< 30 | 51 | 50 | |
OGTT Test Period | 2nd quarter | 29 | 28,4 |
3rd quarter | 64 | 62.7 | |
Not determined | 9 | 8.8 | |
OPGH 75 Test | Positive | 24 | 23.5 |
Negative | 78 | 76.5 |
Gestational diabetes | |||
---|---|---|---|
Yes (n=24) | No (n=78) | ||
Age (years) | < 30 | 19 (18.6) | 28 (27.5) |
> 30 | 5 (4.9) | 50 (49) | |
Test period | 2nd quarter | 18 (17.6) | 20 (19.6) |
3rd quarter | 6 (5.9) | 58 (56.9) |
Characteristics | General population | Gestational diabetes | ||
---|---|---|---|---|
Yes | No | p | ||
Age (years) | 29.1±5.9 | 29.9±6.4 | 28.8±5.7 | 0,480 |
H0 blood glucose (g/l) | 0.8±0.2 | 1±0.2 | 0.7±0.1 | < 0.0001* |
H1 blood glucose (g/l) | 1.4±0.3 | 1.8±0.3 | 1.2±0.2 | < 0.0001* |
H2 blood glucose (g/l) | 1.2±0.4 | 1.7±0.4 | 1.1±0.2 | < 0.0001* |
Total cholesterol | 1.9±0.6 | 2±0.8 | 1.8±0.6 | 0.340 |
HDL cholesterol | 0.7±0.2 | 0.7±0.3 | 0.7±0.2 | 0.896 |
LDL cholesterol | 1.1±0.5 | 1.2±0.6 | 1±0.4 | 0.265 |
Triglycerides | 1.2±0.6 | 1.4±0.7 | 1.1±0.5 | 0.019* |
Insulin | 9.7±22.6 | 21.1±44.7 | 6.1±4.4 | 0.115 |
HOMA-IR | 2.4±8.4 | 6.4±16.8 | 1.2±0.9 | 0.138 |
TyG_H0 | 8.3±0.5 | 8.8±0.5 | 8.2±0.5 | < 0.0001* |
TyG_H1 | 9.3±0.4 | 9.6±0.3 | 9.2±0.4 | < 0.0001* |
TyG_H2 | 8.7±0.5 | 9.1±0.4 | 8.6±0.4 | < 0.0001* |
TyG-H0 | TyG-H1 | TyG-H2 | ||||
---|---|---|---|---|---|---|
r | p | r | p | r | p | |
Age | 0.214 | 0.031 | 0.110 | 0.273 | 0.027 | 0.785 |
H0 blood glucose (g/l) | 0.463 | < 0.0001 | 0.386 | < 0.0001 | 0.250 | 0.008 |
H1 blood glucose (g/l) | 0.400 | < 0.0001 | 0.725 | < 0.0001 | 0.448 | < 0.0001 |
H2 blood glucose (g/l) | 0.419 | < 0.0001 | 0.566 | < 0.0001 | 0.613 | < 0.0001 |
Total cholesterol | 0.612 | < 0.0001 | 0.534 | < 0.0001 | 0.793 | < 0.0001 |
HDL cholesterol | 0.353 | < 0.0001 | 0.497 | < 0.0001 | 0.480 | < 0.0001 |
LDL cholesterol | 0.555 | < 0.0001 | 0.458 | < 0.0001 | 0.796 | < 0.0001 |
Triglycerides (g/l) | 0.885 | < 0.0001 | 0.504 | < 0.0001 | 0.631 | < 0.0001 |
Insulin | 0.223 | 0.025 | 0.206 | 0.038 | 0.171 | 0.151 |
IR-HOMA | 0.314 | 0.001 | 0.405 | < 0.0001 | 0.330 | 0.001 |
Clues | Cut-off | Se | Sp | AUC (CI) | p |
---|---|---|---|---|---|
TyG-H0 | 8.37 | 83.3 | 64.1 | 0.808 (0.70 – 0.92) | 0.000 <1 |
TyG-H1 | 9.50 | 79.2 | 71.8 | 0.818 (0.70 – 0.93 | |
TyG-H2 | 8.88 | 70.8 | 83.3 | 0.799 (0.69 – 0.91) | |
HOMA-IR | 1.63 | 62.5 | 79.5 | 0.746 (0.63 – 0.86) |
Gestational diabetes | |||||
---|---|---|---|---|---|
Yes (n=24) | No (n=78) | OR (IC) | p | ||
TyG-H0 | Yes | 19 (18.6) | 28 (27.5) | 6.79 (2.3 – 20.1) | < 0.0001* |
No | 5 (4.9) | 50 (49) | |||
TyG-H1 | Yes | 18 (17.6) | 20 (19.6) | 8.7 (3 – 25) | < 0.0001* |
No | 6 (5.9) | 58 (56.9) | |||
TyG-H2 | Yes | 16 (15.7) | 13 (12.7) | 10 (3.5 – 28.2) | < 0.0001* |
No | 8 (7.8) | 65 (63.7) | |||
HOMA-IR | Yes | 8 (7.8) | 6 (5.9) | 6 (1.8 – 19.7) | 0.004 |
No | 16 (15.7) | 72 (70.6) |
AUC | Area Under the Curve |
CI | Confidence Interval |
FBG | Fasting Blood Glucose |
GDM | Gestational Diabetes Mellitus |
HDL | High-Density Lipoprotein |
HOMA-IR | Homeostasic Model Assessment of Insulin Resistance |
LDL | Low-Density Lipoprotein |
OGTT | Ora Glucose Tolerance Test |
ROC | Receiver Operating Characteristic |
Se | Sensitivity |
Sp | Specificity |
TyG | Triglycerides-Glucose Index |
WHO | World Health Organization |
WA | Weeks of Amenorrhea |
[1] | W. Ye, C. Luo, J. Huang, C. Li, Z. Liu, and F. Liu, “Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis,” BMJ, vol. 377, 2022, |
[2] | Leye A et al., “Forte prévalence du diabète gestationnel dépisté selon les critères de l’IADPSG en milieu hospitalier dakarois: résultats préliminaires d’une étude transversale au CHUN de Pikine,” Revue Africaine de Médecine Interne (RAFMI), vol. 4, no. 1, pp. 48–55, 2017. |
[3] | G. M. Reaven, “Role of Insulin Resistance in Human Disease,” Diabetes, vol. 37, no. 12, pp. 1595–1607, Dec. 1988, |
[4] | E. U. Alejandro et al., “Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes,” Int J Mol Sci, vol. 21, no. 14, pp. 1–21, Jul. 2020, |
[5] | J. F. Plows, J. L. Stanley, P. N. Baker, C. M. Reynolds, and M. H. Vickers, “The Pathophysiology of Gestational Diabetes Mellitus,” Int J Mol Sci, vol. 19, no. 11, Nov. 2018, |
[6] | S. Wang et al., “Stronger association of triglyceride glucose index than the HOMA-IR with arterial stiffness in patients with type 2 diabetes: a real-world single-centre study,” Cardiovasc Diabetol, vol. 20, no. 1, pp. 1–10, Dec. 2021, |
[7] | T. Du, G. Yuan, M. Zhang, X. Zhou, X. Sun, and X. Yu, “Clinical usefulness of lipid ratios, visceral adiposity indicators, and the triglycerides and glucose index as risk markers of insulin resistance,” Cardiovasc Diabetol, vol. 13, no. 1, pp. 1–10, Oct. 2014, |
[8] | H. M. Park, H. S. Lee, Y. J. Lee, and J. H. Lee, “The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance,” Diabetes Res Clin Pract, vol. 180, p. 109042, Oct. 2021, |
[9] | Soumah IY et al., “STUDY OF CARDIOVASCULAR RISK FACTORS DURING GESTATIONAL DIABETES IN SENEGAL,” Glob J Res Anal, vol. 10, no. 2, pp. 98–102, 2021. |
[10] | W. T. Friedewald, R. I. Levy, and D. S. Fredrickson, “Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge,” Clin Chem, vol. 18, no. 6, pp. 499–502, Jun. 1972, |
[11] | F. Guerrero-Romero et al., “The Product of Triglycerides and Glucose, a Simple Measure of Insulin Sensitivity. Comparison with the Euglycemic-Hyperinsulinemic Clamp,” J Clin Endocrinol Metab, vol. 95, no. 7, pp. 3347–3351, Jul. 2010, |
[12] | D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, Jul. 1985, |
[13] | S. Ozyildirim, H. A. Barman, O. Dogan, M. K. Ersanli, and S. M. Dogan, “The Relationship between Coronary Flow Reserve and the TyG Index in Patients with Gestational Diabetes Mellitus,” Medicina (Lithuania), vol. 59, no. 10, p. 1811, Oct. 2023, |
[14] | H. D. McIntyre, P. Catalano, C. Zhang, G. Desoye, E. R. Mathiesen, and P. Damm, “Gestational diabetes mellitus,” Nat Rev Dis Primers, vol. 5, no. 1, Dec. 2019, |
[15] | N. M. K. SELVI, S. NANDHINI, V. SAKTHIVADIVEL, S. LOKESH, A. R. SRINIVASAN, and S. SUMATHI, “Association of Triglyceride–Glucose Index (TyG index) with HbA1c and Insulin Resistance in Type 2 Diabetes Mellitus,” Maedica (Bucur), vol. 16, no. 3, p. 375, Sep. 2021, |
[16] | T. D. Wu et al., “Association of Triglyceride-Glucose Index and Lung Health: A Population-Based Study,” Chest, vol. 160, no. 3, pp. 1026–1034, Sep. 2021, |
[17] | J. S. Yoon, H. J. Lee, H. R. Jeong, Y. S. Shim, M. J. Kang, and I. T. Hwang, “Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents,” Endocr J, vol. 69, no. 5, pp. 559–565, 2022, |
[18] | Y. Zeng, L. Yin, X. Yin, and D. Zhao, “Association of triglyceride-glucose index levels with gestational diabetes mellitus in the US pregnant women: a cross-sectional study,” Front Endocrinol (Lausanne), vol. 14, p. 1241372, Oct. 2023, |
[19] | Y. Guo et al., “Triglyceride-glucose index in early pregnancy predicts the risk of gestational diabetes: a prospective cohort study,” Lipids Health Dis, vol. 23, no. 1, pp. 1–12, Dec. 2024, |
APA Style
Souleymane, T., Yaya, S. I., Adourahmane, S., Fatou, D., Thorpe, D. F. K. S., et al. (2024). Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test. Advances in Biochemistry, 12(3), 92-98. https://doi.org/10.11648/j.ab.20241203.11
ACS Style
Souleymane, T.; Yaya, S. I.; Adourahmane, S.; Fatou, D.; Thorpe, D. F. K. S., et al. Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test. Adv. Biochem. 2024, 12(3), 92-98. doi: 10.11648/j.ab.20241203.11
AMA Style
Souleymane T, Yaya SI, Adourahmane S, Fatou D, Thorpe DFKS, et al. Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test. Adv Biochem. 2024;12(3):92-98. doi: 10.11648/j.ab.20241203.11
@article{10.11648/j.ab.20241203.11, author = {Thiam Souleymane and Soumah Idrissa Yaya and Samba Adourahmane and Diedhiou Fatou and Dia Fatou Kine Sy Thorpe and Ba Ramatoulaye and Tounkara Abdoulaye Racine and Agossou Hortence Honrine Medece and Coly Najah Fatou and Diouf Niokhor N. dande and Ndiaye Arame and Doupa Dominique and Cisse Fatou and Diatta Alassane and Diallo Fatou}, title = {Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test }, journal = {Advances in Biochemistry}, volume = {12}, number = {3}, pages = {92-98}, doi = {10.11648/j.ab.20241203.11}, url = {https://doi.org/10.11648/j.ab.20241203.11}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ab.20241203.11}, abstract = {The Triglyceride-Glucose (TyG) index is a marker used to assess insulin resistance which is associated with the occurrence of gestational diabetes. The aim of this study is to determine the benefit of the TyG within the diagnosis of insulin resistance in pregnant women in an orally induced hyperglycaemia test. This study was conducted at the Department of Biochemistry, at Aristide le Dantec University Hospital in collaboration with the department of gynaecology. Women with fasting blood glucose 1 index was 9.5 with a sensitivity and specificity of 79.2% and 71.8%, respectively. The TyG index is a better way to assess the level of insulin resistance in pregnant women than using the HOMA index, especially after the first hour of a glucose load of 75g.}, year = {2024} }
TY - JOUR T1 - Contribution of the Triglycerides-Glucose Index (TyG) in the Assessment of Insulin Resistance in Pregnant Women During an OGTT Test AU - Thiam Souleymane AU - Soumah Idrissa Yaya AU - Samba Adourahmane AU - Diedhiou Fatou AU - Dia Fatou Kine Sy Thorpe AU - Ba Ramatoulaye AU - Tounkara Abdoulaye Racine AU - Agossou Hortence Honrine Medece AU - Coly Najah Fatou AU - Diouf Niokhor N. dande AU - Ndiaye Arame AU - Doupa Dominique AU - Cisse Fatou AU - Diatta Alassane AU - Diallo Fatou Y1 - 2024/07/29 PY - 2024 N1 - https://doi.org/10.11648/j.ab.20241203.11 DO - 10.11648/j.ab.20241203.11 T2 - Advances in Biochemistry JF - Advances in Biochemistry JO - Advances in Biochemistry SP - 92 EP - 98 PB - Science Publishing Group SN - 2329-0862 UR - https://doi.org/10.11648/j.ab.20241203.11 AB - The Triglyceride-Glucose (TyG) index is a marker used to assess insulin resistance which is associated with the occurrence of gestational diabetes. The aim of this study is to determine the benefit of the TyG within the diagnosis of insulin resistance in pregnant women in an orally induced hyperglycaemia test. This study was conducted at the Department of Biochemistry, at Aristide le Dantec University Hospital in collaboration with the department of gynaecology. Women with fasting blood glucose 1 index was 9.5 with a sensitivity and specificity of 79.2% and 71.8%, respectively. The TyG index is a better way to assess the level of insulin resistance in pregnant women than using the HOMA index, especially after the first hour of a glucose load of 75g. VL - 12 IS - 3 ER -